Pancreatic cancer mystery deepens as researchers make unexpected discovery

A University of Cincinnati study found differences in pancreatic tumors that could help explain why that type of cancer affects some patients differently, potentially leading to more personalized treatments.Researchers examined 22 pancreatic tumors from patients of different racial backgrounds across the U.S., looking for differences in cancer cells and how the immune system responds to them.The study included seven Black patients and 15 non-African American patients.The findings were published in the journal Cancer Research.FDA APPROVES ONCE-DAILY PILL FOR DEADLY CANCER AFTER PATIENTS' SURVIVAL RATES NEARLY DOUBLETumors from Black patients had fewer of the most common type of pancreatic cancer cells and more cells with a mix of different characteristics, the researchers found.Some of those cell characteristics have been associated with drug resistance, but the study did not establish whether they affected patients’ treatment outcomes.A University of Cincinnati study found differences in pancreatic tumors that could help explain why that type of cancer affects some patients differently.
(iStock)Additionally, tumors from Black patients contained more B cells, a type of immune cell, and larger clusters of immune cells.Researchers found signs that some B cells may suppress the body’s response to cancer, although the significance of these differences is unclear.PATIENTS REMAIN CANCER-FREE NEARLY 3 YEARS AFTER RECEIVING EXPERIMENTAL IMMUNOTHERAPYDr.
Raymond Wadlow, a gastrointestinal medical oncologist at Inova Schar Cancer Institute in Virginia, said that using immunotherapy to help the immune system attack the disease has been particularly challenging in pancreatic cancer."That's been very difficult to do in pancreatic cancer because the pancreatic tumor subverts the immune system so that it is fighting for it instead of for the host or the rest of the body," Wadlow, who was not involved in the study, told Fox News Digital.Tumors from Black patients contained mor...